TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
about
Recent insights into the biological activities and drug delivery systems of tanshinonesSynthesis, characterization and anti-cancer activity of Pluronic F68-curcumin conjugate micelles.Bioavailability and pharmacokinetic comparison of tanshinones between two formulations of Salvia miltiorrhiza in healthy volunteers.Caffeine exposure alters cardiac gene expression in embryonic cardiomyocytes.D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel deliveryInhibition of Growth and Metastasis of Colon Cancer by Delivering 5-Fluorouracil-loaded Pluronic P85 Copolymer MicellesVitamin E succinate-conjugated F68 micelles for mitoxantrone delivery in enhancing anticancer activity.Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokineticsGlycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.Effects of X-shaped reduction-sensitive amphiphilic block copolymer on drug delivery.Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery.Encapsulation of Sesbania grandiflora extract in polymeric micelles to enhance its solubility, stability, and antibacterial activity.Recent Advances in the Application of Vitamin E TPGS for Drug Delivery.Redox-sensitive micelles composed of disulfide-linked Pluronic-linoleic acid for enhanced anticancer efficiency of brusatol.A simply triggered peptide-based hydrogel as an injectable nanocarrier of tanshinone IIA and tanshinones.Tanshinone IIA reduces SW837 colorectal cancer cell viability via the promotion of mitochondrial fission by activating JNK-Mff signaling pathways
P2860
Q26770498-EE4BCE88-73F4-466F-ACB5-684F3E258EEBQ30970127-5A9C6894-0117-4E79-AA52-87D354219F7EQ33875360-BFB23B80-5296-4BB9-8A35-BA12231951CBQ34726685-24A624CF-E6C5-4426-B924-84B49F9C6818Q35994325-8AA0CFB4-054B-4B74-A7CD-6AD6553DC2DAQ36569707-AAA7AE33-FEEB-45D3-BEA1-71792715E0CFQ37103470-5BAA22DE-FC41-4117-94B2-8310B76605BCQ37707038-94B3775F-514D-4129-9A06-AC646E53EABFQ38826497-B0011D5E-A44B-4350-AB22-ED24A1DE1457Q38837166-58D366E9-D405-4C0D-A34B-F89C61E389BFQ38937032-09AAC536-F8B2-4205-B86E-3850B1F37B32Q40367825-682D2B77-F6C0-4F8C-B8EA-965483FD4848Q47164896-8B12972F-84B0-43A3-86E1-33B2CC892F83Q52680601-CC8999CB-256A-4ADD-B374-82E24EC2BBA4Q53632854-F404806B-55D5-4AE2-AD65-1515E1CB9AD1Q58698260-854389F3-406A-420A-B510-32D247EDA989
P2860
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
@en
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
@nl
type
label
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
@en
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
@nl
prefLabel
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
@en
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
@nl
P2093
P1476
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
@en
P2093
Demin Zhou
Jinming Zhang
Meiwan Chen
Xiefan Fang
Yitao Wang
P304
P356
10.1016/J.IJPHARM.2014.09.017
P407
P577
2014-09-16T00:00:00Z